Ausgabe 12/2021
Inhalt (38 Artikel)
Gender balance in the editorial board of nuclear medicine journals
Laura Evangelista, Ozgul Ekmekcioglu, Jolanta Kunikowska
Can someone look after my children while I write this COVID-19 paper?
Elske Quak, Gilles Girault, Charline Lasnon
First clinical experience of 106 cm, long axial field-of-view (LAFOV) PET/CT: an elegant balance between standard axial (23 cm) and total-body (194 cm) systems
Xiaoli Lan, Muhsin H. Younis, Ke Li, Weibo Cai
The increasing potential of nuclear medicine imaging for the evaluation and reduction of normal tissue toxicity from radiation treatments
V. Mohan, N. M. Bruin, J. B. van de Kamer, J.-J. Sonke, Wouter V. Vogel
To 1000 Gy and back again: a systematic review on dose-response evaluation in selective internal radiation therapy for primary and secondary liver cancer
Joey Roosen, Nienke J. M. Klaassen, Lovisa E. L. Westlund Gotby, Christiaan G. Overduin, Marcel Verheij, Mark W. Konijnenberg, J. Frank W. Nijsen
Distributed learning: a reliable privacy-preserving strategy to change multicenter collaborations using AI
Margarita Kirienko, Martina Sollini, Gaia Ninatti, Daniele Loiacono, Edoardo Giacomello, Noemi Gozzi, Francesco Amigoni, Luca Mainardi, Pier Luca Lanzi, Arturo Chiti
Artificial intelligence is a promising prospect for the detection of prostate cancer extracapsular extension with mpMRI: a two-center comparative study
Ying Hou, Yi-Hong Zhang, Jie Bao, Mei-Ling Bao, Guang Yang, Hai-Bin Shi, Yang Song, Yu-Dong Zhang
Deep learning for whole-body medical image generation
Joshua Schaefferkoetter, Jianhua Yan, Sangkyu Moon, Rosanna Chan, Claudia Ortega, Ur Metser, Alejandro Berlin, Patrick Veit-Haibach
International consensus on the use of [18F]-FDG PET/CT in pediatric patients affected by epilepsy
Mei Tian, Yasuyoshi Watanabe, Keon Wook Kang, Koji Murakami, Arturo Chiti, Ignasi Carrio, A. Cahid Civelek, Jianhua Feng, Yuankai Zhu, Rui Zhou, Shuang Wu, Junming Zhu, Yao Ding, Kai Zhang, Hong Zhang
Effects of two patient-specific dosing protocols on measurement of myocardial blood flow with 3D 82Rb cardiac PET
Liliana Arida-Moody, Jonathan B Moody, Jennifer M Renaud, Alexis Poitrasson-Rivière, Tomoe Hagio, Anne M Smith, Edward P Ficaro, Venkatesh L Murthy
Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis
Manon Bordonne, Mohammad B. Chawki, Matthieu Doyen, Aurelie Kas, Eric Guedj, Louise Tyvaert, Antoine Verger
PET imaging of neural activity, β-amyloid, and tau in normal brain aging
Kai Zhang, Hiroshi Mizuma, Xiaohui Zhang, Kayo Takahashi, Chentao Jin, Fahuan Song, Yuanxue Gao, Yousuke Kanayama, Yuping Wu, Yuting Li, Lijuan Ma, Mei Tian, Hong Zhang, Yasuyoshi Watanabe
Feasibility of short imaging protocols for [18F]PI-2620 tau-PET in progressive supranuclear palsy
Mengmeng Song, Maximilian Scheifele, Henryk Barthel, Thilo van Eimeren, Leonie Beyer, Ken Marek, Florian Eckenweber, Carla Palleis, Lena Kaiser, Anika Finze, Maike Kern, Alexander Nitschmann, Gloria Biechele, Sabrina Katzdobler, Gèrard Bischof, Jochen Hammes, Frank Jessen, Dorothee Saur, Matthias L. Schroeter, Jost-Julian Rumpf, Michael Rullmann, Andreas Schildan, Marianne Patt, Bernd Neumaier, Andrew W. Stephens, Boris-Stephan Rauchmann, Robert Perneczky, Johannes Levin, Joseph Classen, Günter U. Höglinger, Peter Bartenstein, Guido Boening, Sibylle Ziegler, Victor Villemagne, Alexander Drzezga, John Seibyl, Osama Sabri, Matthias Brendel
Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis
K. S. M. van der Geest, G. Treglia, A. W. J. M. Glaudemans, E. Brouwer, M. Sandovici, F. Jamar, O. Gheysens, R. H. J. A. Slart
Positron emission tomography in the COVID-19 pandemic era
Chentao Jin, Xiaoyun Luo, Shufang Qian, Kai Zhang, Yuanxue Gao, Rui Zhou, Peili Cen, Zhoujiao Xu, Hong Zhang, Mei Tian
Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT
Stefan A. Koerber, R. Finck, K. Dendl, M. Uhl, T. Lindner, C. Kratochwil, M. Röhrich, H. Rathke, G. Ungerechts, S. Adeberg, K. Herfarth, D. Jaeger, J. Debus, U. Haberkorn, F. L. Giesel
Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas
R. Laudicella, N. Quartuccio, G. Argiroffi, P. Alongi, L. Baratto, E. Califaretti, V. Frantellizzi, G. De Vincentis, A. Del Sole, L. Evangelista, S. Baldari, S. Bisdas, Francesco Ceci, Andrei Iagaru
Prognostic value of [18F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies
Simone Krebs, Audrey Mauguen, Onur Yildirim, Vaios Hatzoglou, Jasmine H. Francis, Lauren R. Schaff, Ingo K. Mellinghoff, Heiko Schöder, Christian Grommes
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity – initial experience and comparison to [18F]FDG PET/CT and MRI
Christian Linz, Roman C. Brands, Olivia Kertels, Alexander Dierks, Joachim Brumberg, Elena Gerhard-Hartmann, Stefan Hartmann, Andreas Schirbel, Sebastian Serfling, Yingjun Zhi, Andreas K. Buck, Alexander Kübler, Julian Hohm, Constantin Lapa, Malte Kircher
Structural and functional radiomics for lung cancer
Guangyao Wu, Arthur Jochems, Turkey Refaee, Abdalla Ibrahim, Chenggong Yan, Sebastian Sanduleanu, Henry C. Woodruff, Philippe Lambin
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions
Chukwuka Eze, Nina-Sophie Schmidt-Hegemann, Lino Morris Sawicki, Julian Kirchner, Olarn Roengvoraphoj, Lukas Käsmann, Lena M. Mittlmeier, Wolfgang G. Kunz, Amanda Tufman, Julien Dinkel, Jens Ricke, Claus Belka, Farkhad Manapov, Marcus Unterrainer
Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancer
Rhea Chitalia, Varsha Viswanath, Austin R. Pantel, Lanell M. Peterson, Aimilia Gastounioti, Eric A. Cohen, Mark Muzi, Joel Karp, David A. Mankoff, Despina Kontos
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance
C. Bezzi, P. Mapelli, L. Presotto, I. Neri, P. Scifo, A. Savi, V. Bettinardi, S. Partelli, L. Gianolli, M. Falconi, M. Picchio
Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management
Wolfgang Roll, Matthias Weckesser, Robert Seifert, Lisa Bodei, Kambiz Rahbar
Factors predicting biochemical response and survival benefits following radioligand therapy with [177Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review
Reyhaneh Manafi-Farid, Sara Harsini, Bahare Saidi, Hojat Ahmadzadehfar, Ken Herrmann, Alberto Briganti, Jochen Walz, Mohsen Beheshti
What’s behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns
Jan H. Rüschoff, Daniela A. Ferraro, Urs J. Muehlematter, Riccardo Laudicella, Thomas Hermanns, Ann-Katrin Rodewald, Holger Moch, Daniel Eberli, Irene A. Burger, Niels J. Rupp
Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[18F]FDG PET/CT
Caixia Wu, Yonggang Cui, Jumei Liu, Linlin Ma, Yan Xiong, Yanqing Gong, Yanyan Zhao, Xi Zhang, Silu Chen, Qun He, Jianhua Zhang, Meng Liu, Yan Fan
The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study
Hojjat Ahmadzadehfar, Ralf Matern, Richard P. Baum, Robert Seifert, Katharina Kessel, Martin Bögemann, Clemens Kratochwil, Hendrik Rathke, Harun Ilhan, Hanna Svirydenka, Mike Sathekge, Levent Kabasakal, Anna Yordanova, Francisco Osvaldo Garcia-Perez, Kalevi Kairemo, Masha Maharaj, Diana Paez, Irene Virgolini, Kambiz Rahbar
Comparison of pretherapeutic osseous tumor volume and standard hematology for prediction of hematotoxicity after PSMA-targeted radioligand therapy
Liam Widjaja, Rudolf A. Werner, Tobias L. Ross, Frank M. Bengel, Thorsten Derlin
68Ga-FAPI-PET/CT in patients with various gynecological malignancies
Katharina Dendl, Stefan A. Koerber, Rebecca Finck, Kgomotso M. G. Mokoala, Fabian Staudinger, Lisa Schillings, Ulrike Heger, Manuel Röhrich, Clemens Kratochwil, Mike Sathekge, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Frederik L. Giesel
Demonstration of in vivo estrogen receptor status with 16α- [18F]fluoro-17ß-oestradiol (FES) PET/CT in a rare case of benign metastasizing leiomyoma
Duygu Has Simsek, Serkan Kuyumcu, Zeynep Gozde Ozkan, Dogu Vuralli Bakkaloglu, Aysel Bayram, Samet Topuz, Adnan Aydıner, Yasemin Sanli
Intense [68Ga]Ga-FAPI-04 uptake in solitary fibrous tumor/hemangiopericytoma of the central nervous system
Ying Zhang, Jiawei Cai, Zanyi Wu, Shaobo Yao, Weibing Miao
Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET
Pascalle Mossel, Lara Garcia Varela, Wejdan M. Arif, Chris W. J. van der Weijden, Hendrikus H. Boersma, Antoon T. M. Willemsen, Ronald Boellaard, Philip H. Elsinga, Ronald J. H. Borra, Nicola A. Colabufo, Jun Toyohara, Peter Paul de Deyn, Rudi A. J. O. Dierckx, Adriaan A. Lammertsma, Anna L. Bartels, Gert Luurtsema
PET/CT imaging of pancreatic carcinoma targeting the “cancer integrin” αvβ6
Neil Gerard Quigley, Norbert Czech, Wolfgang Sendt, Johannes Notni
Correction to: Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancer
Rhea Chitalia, Varsha Viswanath, Austin R. Pantel, Lanell M. Peterson, Aimilia Gastounioti, Eric A. Cohen, Mark Muzi, Joel Karp, David A. Mankoff, Despina Kontos